Musculoskeletal Key

Carpal tunnel syndrome Associated with primary Raynaud’s phenomenon Associated with systemic sclerosis (in particular early, rapidly progressive diffuse cutaneous disease) Drugs and toxins Immunosuppressive agents Chemotherapeutic agents Drugs used in…

Outcome measure Primary outcome measure (number of trials) Other outcome measures assessed (number of trials) Frequency of attacks 11 [7, 8, 16–24] 5 [25–29] Duration of attacks 6 [7, 8,…

Fig. 20.1 Treatment of Raynaud’s phenomenon (RP) Treatment Approach Indications for Drug Therapy Severe RP that is impacting quality of life despite non-pharmacologic therapy. Raynaud’s events with signs of ischemia–reperfusion…

Fig. 15.1 Illustration demonstrating principle of autoantibody identification by indirect immunofluorescence Fig. 15.2 Examples of IIF staining patterns that can be found in patients with RP secondary to autoimmune rheumatic…

Fig. 1.1 The cover page of Raynaud’s 1862 original medical thesis Pathogenetic Mechanisms Investigations into the pathogenesis of RP have been a long path lasting more than 150 years. Just…

Fig. 2.1 Note the demarcated pale coloration of the fingers typical of the pallor phase of Raynaud’s phenomenon Fig. 2.2 Fingers showing the cyanotic phase of Raynaud’s phenomenon in a…

Exposure Prevalence (%) Additional information References Vibration  Pneumatic drillers, knives, hammers, rock breakers, grinders, chippers 30.2–45 Commonly used in quarries, by stone cutters [72–77] Halving the years of exposure allows…